Prevnar 20
Payments companies reported to CMS as associated with Prevnar 20. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Prevnar 20, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Prevnar 20
These are the largest totals companies reported as associated with Prevnar 20. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jana Shaw | Watertown, NY | Pediatric Infectious Diseases | $107,683.71 |
| Elizabeth Race | Dallas, TX | Infectious Disease | $71,386.76 |
| Ruth Carrico | Chicago, IL | Family | $69,261.68 |
| Jaime Fergie | Corpus Christi, TX | Pediatric Infectious Diseases | $66,732.46 |
| Stephen Pelton | Boston, MA | Pediatric Infectious Diseases | $62,911.92 |
| Rotem Lapidot | Boston, MA | Pediatric Infectious Diseases | $59,261.00 |
| Eric Simoes | Aurora, CO | Pediatric Infectious Diseases | $42,789.60 |
| Brett Gilbert | Wynnewood, PA | Infectious Disease | $42,632.37 |
| Julio Ramirez | Louisville, KY | Infectious Disease | $42,597.76 |
| Frances Ferguson | Newton, GA | Internal Medicine | $40,719.61 |
Prescribed Prevnar 20?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.